Relay receives HemoPalm patent in ChinaRelay receives HemoPalm patent in China 2020-01-07 16:04 ET - News Release Mr. W. Clark Kent reports UPDATE: RELAY MEDICAL JOINT SPECTROSCOPIC AND BIOSENSOR SYSTEM FOR POINT-OF-CARE TESTING PATENT GRANTED IN CHINA Relay Medical Corp. has provided an update to the Sept. 12 news release regarding the approval for grant of Chinese patent application No. 201580025752.6. The company has been informed that the patent has been officially granted by the Chinese patent authority as patent No. CN106716137B with an expiry date of May 20, 2035. This new patent continues to expand the broad reach of Relay's intellectual property portfolio for its HemoPalm analysis platform in a rapidly advancing market for health care technologies. About Relay Medical Corp.